Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-02-11T18:25:50.433Z Has data issue: false hasContentIssue false

USING APPROPRIATE COMPARISONS IN ECONOMIC EVALUATIONS

An Exercise in Belgium

Published online by Cambridge University Press:  01 January 1999

Olivier Van Tiggelen
Affiliation:
Free University of Brussels (VUB)
Guy Storme
Affiliation:
Free University of Brussels (VUB)
Koen Torfs
Affiliation:
European Organisation for Research and Treatment of Cancer (EORTC)
Dirk Van den Berge
Affiliation:
Free University of Brussels (VUB)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This paper considers standard effective treatments for non-Hodgkin's lymphoma and early breast cancer in premenopausal women. The literature assesses the treatments' effectiveness, and expected charges for different treatments in the context of the Belgian Health Insurance System are compared. Ovariectomy in breast cancer (770 ECU) and conventional chemotherapy in non-Hodgkin (2,745 lymphoma ECU) prove equally effective and are less costly in comparison with chemotherapy (1,904 ECU) in breast cancer or chemotherapy and autologous bone marrow transplantation (19,262 ECU) in non-Hodgkin's lymphoma. Further unbiased insights in competitive treatments' costs and outcome could save money and enhance developments in cancer care.

Type
RESEARCH NOTES
Copyright
© 1999 Cambridge University Press